References
- Abbruzzese JL, Abbruzzese MC, Hess KR, et al. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994; 12(6): 1272–80
- Lembersky BC, Thomas LC. Metastases of unknown primary site. Med Clin North Am 1996; 80(1): 153–71
- Daugaard G. Unknown primary tumours. Cancer Treat Rev 1994; 20(2): 119–47
- Kirsten F, Chi CH, Leary JA, et al. Metastatic adeno or undifferentiated carcinoma from an unknown primary site: natural history and guidelines for identification of treatable subsets. Q J Med 1987; 62(238): 143–61
- Motzer RJ, Rodriguez E, Reuter VE, et al. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 1995; 13(1): 274–82
- Mackay B, Ordonez NG. Pathological evaluation of neoplasms with unknown primary tumor site. Semin Oncol 1993; 20(3): 206–28
- Garrow GC, Greco FA, Hainsworth JD. Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site. Semin Oncol 1993; 20(3): 287–91
- Le Chevalier T, Cvitkovic E, Caille P, et al. Early metastatic cancer of unknown primary origin at presentation: a clinical study of 302 consecutive autopsied patients. Arch Intern Med 1988; 148(9): 2035–9
- Sporn JR, Greenberg BR. Empiric chemotherapy in patients with carcinoma of unknown primary site. Am J Med 1990; 88(1): 49–55
- Karsell PR, Sheedy PF 2d, O'Connell MJ. Computed tomography in search of cancer of unknown origin. JAMA 1982; 248(3): 340–3
- McMillan JH, Levine E, Stephens RH. Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site: a retrospective study. Radiology 1982; 143(1): 143–6
- Pavlidis N, Kalef-Ezra J, Briassoulis E, et al. Evaluation of six tumor markers in patients with carcinoma of unknown primary. Med Pediatr Oncol 1994; 22(3): 162–7
- de Braud F, al-Sarraf M. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol 1993; 20(3): 273–8
- Baron PL, Moore MP, Kinne DW, et al. Occult breast cancer presenting with axillary metastases: updated management. Arch Surg 1990; 125(2): 210–4
- Bhatia SK, Saclarides TJ, Witt TR, et al. Hormone receptor studies in axillary metastases from occult breast cancers. Cancer 1987; 59(6): 1170–2
- Ellerbroek N, Holmes F, Singletary E, et al. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 1990; 66(7): 1461–7
- Muggia FM, Baranda J. Management of peritoneal carcinomatosis of unknown primary tumor site. Semin Oncol 1993; 20(3): 268–72
- Guarischi A, Keane TJ, Elhakim T. Metastatic inguinal nodes from an unknown primary neoplasm: a review of 56 cases. Cancer 1987; 59(3): 572–7
- Gentile PS, Carloss HW, Huang TY, et al. Disseminated prostatic carcinoma simulating primary lung cancer: indications for immunodiagnostic studies. Cancer 1988; 62(4): 711–5
- Gamble AR, Bell JA, Ronan JE, et al. Use of tumour marker immunoreactivity to identify primary site of metastatic cancer. BMJ 1993; 306(6873): 295–8
- Greco FA, Vaughn WK, Hainsworth JD. Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome. Ann Intern Med 1986; 104(4): 547–53
- Greco FA, Hainsworth JD. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy. Semin Oncol 1994; 21(5 Suppl 12): 77–82
- van der Gaast A, Verweij J, Planting AS, et al. Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site. Clin Oncol 1995; 13(7): 1720–5